MaaT Pharma
Muriel Prudent is an Investor at Bpifrance, French public investment bank, managing a portfolio of health- and other deeptech startups within the PSIM Fund, which focuses on major tech disruptions. Graduated from HEC Paris and Bocconi University in Milan.
This person is not in the org chart
This person is not in any offices
MaaT Pharma
We are a clinical stage oncology company and industry leader in microbiome restoration therapy using biotherapeutics to treat life-threatening diseases.